AUS
NZ
UK
CA
USA
IND
Healt
Noxopharm Presented Highly Encouraging Veyonda® Clinical Data at ASCO 2020 Annual Meeting
June 03, 2020 11:42 AM AEST| By Team Kalkine MediaSummary Noxopharm presented two sets of clinical data concerning the development of Veyonda® as a treatment for end-stage prostate cancer at ASCO 2020 Annual Meeting. Highly encouraging interim data from the Phase 1b/2a LuPIN clinical trial.....
The Effectiveness of Physical Distancing: Is 1-meter distance enough?
June 02, 2020 07:48 PM AEST| By Kunal SawhneySummary According to WHO, everyone should maintain a 1-meter (3 feet) distance, and the CDC has said to keep a 6 feet distance to avoid the contact of small liquid droplets of the virus. Emerging evidence from various studies across the globe i.....
COVID-19 Vaccine Development: Updates from Novartis, Moderna and Novavax
June 01, 2020 10:02 PM AEST| By Hina ChowdharySummary Many scientific experiments are underway for the development of a vaccine against COVID-19 which has taken 370,657 lives and infected over 6.04 million people across the globe (01 June 2020 at 11:11 AM CEST). There are more than 100 of .....
Skin Elements’ Natural Plant-Based SE FormulaTM 99.99% effective against Feline Coronavirus
June 01, 2020 01:04 PM AEST| By Team Kalkine MediaSummary COVID-19 outbreak enhanced the popularity of the Invisi Shield® Natural Life as the demand for the sanitiser soar amidst hygiene concerns. The efficacy of Skin Element’s product against Feline Coronavirus augments its lucrativ.....
5 Healthcare Stocks Riding High Amid Buoyed COVID-19-induced Healthcare Opportunities
May 30, 2020 12:00 AM AEST| By Team Kalkine MediaDespite several ASX-listed companies battling during these uncertain and challenging times, the healthcare companies have seen a silver lining. While the COVID-19 pandemic has negatively impacted most of the businesses, some have generated impressi.....
How is the Global Biotech Player CSL Limited Responding to COVID-19?
May 29, 2020 08:49 PM AEST| By Team Kalkine MediaThe healthcare sector, over the last 12 months, has been one of the best performers on the Australian Securities Exchange (ASX). Some players from the healthcare industry in Australia have witnessed a substantial increase in share price in the curr.....
Imugene’s Preclinical New Mimotope Cancer Vaccine Research Published in Prestigious Journal
May 29, 2020 05:09 PM AEST| By Team Kalkine MediaSummary Imugene's preclinical research associated with mimotope vaccines targeting immune checkpoint inhibitors published in 'Frontiers in Immunology' journal. Research discovered that mimotope peptides when included in Imugene's exclusive immu.....
Is COVID-19 Australia’s Cue to Strengthen the Manufacturing Sector?
May 28, 2020 10:30 PM AEST| By Hina ChowdharySummary Manufacturing is a vital part of the economy and has survived several challenges On the back of rebalances in its sectors, products, technologies, and supply chains, the industry has streamlined its stance The current pandemic is prope.....
SUDA Reports Significant Preliminary Results from Anagrelide Pharmacokinetic Study
May 28, 2020 05:07 PM AEST| By Team Kalkine MediaSummary SUDA made further progress towards Anagrelide program, attaining significant preliminary results from a pharmacokinetic study. Results support SUDA’s hypothesis that Anagrelide’s mouth spray formulation can lessen the risk o.....
Impressive! Prescient Obtains Key Licenses for Next Generation Immunotherapy Platform
May 28, 2020 11:45 AM AEST| By Team Kalkine MediaSummary Prescient obtains two key licenses from world immunotherapy leader, University of Pennsylvania and Oxford University to create a revolutionary cancer therapy platform called “OmniCAR”. OmniCAR platform would allow extraordin.....
5 Growth Stocks that are Investors’ Favourite during COVID-19
May 28, 2020 12:10 AM AEST| By Kunal SawhneySummary A few growth stocks like Amazon, Google, Microsoft, Tesla, etc have consistently been providing the investors with high yields. Pushpay Holdings delivered an exponential return of 24 per cent on YTD basis (as on 26 May 2020). Nanosoni.....
Radical Shifts to Occur in Popular Index Compositions Amidst COVID-19 Crisis
May 27, 2020 12:00 AM AEST| By Team Kalkine MediaCoronavirus pandemic has profoundly impacted the world, causing a threat to public health, disrupting social and economic dynamics while affecting long-term livelihoods and well-being of millions. Market analysts and experts are fearing a r.....
Nyrada Announces Milestone Achieved in Brain Injury Program; Strong Leadership Fostering Success Story
May 26, 2020 05:06 PM AEST| By Team Kalkine MediaAustralian preclinical stage and publicly listed drug development company, Nyrada Inc. (ASX: NYR) is marking good progress towards developing novel small molecule drugs targeted at treating neurological, cardiovascular and inflammatory diseases, with...
How Does Gilead’s Antiviral Drug Remdesivir Help to Combat COVID-19?
May 26, 2020 12:35 AM AEST| By Team Kalkine MediaSummary As of now, there are more than 5.2 million confirmed cases of COVID-19, and over 337k deaths have been reported. There is no approved vaccine for COVID-19 although dozens of candidates are under clinical development. Amid this crisis,.....
Airline Industry Stemming for Revival after COVID-19 Disruptions
May 25, 2020 03:23 PM AEST| By Team Kalkine MediaTravel and tourism contributed more than 10% to the Australian economy in 2019, as per WTTC; however, lockdowns and travel restrictions arising from the virus spread severely impacted the industry in first half of 2020. Revival of the travel and .....
Noxopharm’s potential COVID-19 treatment - Lodges pre-IND Submission with FDA for Veyonda® Clinical Trial
May 25, 2020 01:02 PM AEST| By Team Kalkine MediaMarking a step forward, clinical-stage drug development company Noxopharm (ASX:NOX) has lodged a pre-IND (Investigational New Drug) submission with the U.S. Food and Drug Administration (FDA) for a Veyonda® clinical trial in COVID-19 (SARS-C...
Antisense and Invex - Why these two ASX-healthcare Players might be having a good weekend?
May 24, 2020 12:50 AM AEST| By Team Kalkine MediaAmid the unprecedented market instability due to the COVID-19 pandemic, investors are keenly focusing on investing in lucrative shares having the highest value in the market. The coronavirus outbreak has changed the dimensions for the businesses acro...
Biotech player Selvax beating the odds; eyes an IPO in H2’ 20
May 24, 2020 12:10 AM AEST| By Kunal SawhneyThe oncology therapeutic area is still looking for a breakthrough treatment that will establish itself as a go-to-treatment for treating malignancies. Making its way through, a novel cancer immunotherapy treatment has surfaced that provides relativel...
Air pollution likely to reach pre-COVID-19 levels: China sees rise in pollutants post lockdown
May 24, 2020 12:00 AM AEST| By Team Kalkine MediaThe world has seen quality of air deteriorating and amount of pollution levels significantly rising over the last two decades due to burning of fossil fuels in industries and households along with rising number of vehicles on roads. The menace of air...
Can Dimerix follow in the footsteps of Opthea, Paradigm and Antisense?
May 23, 2020 03:25 PM AEST| By Team Kalkine MediaAs the gravity of the coronavirus outbreak continues to intensify, the healthcare sector has been surrounded by the news about the race amongst countries and pharma companies to develop a vaccine for the infectious disease. Several established compan...
Advertise your brand on Kalkine Media